0001618921-22-000100.txt : 20221123 0001618921-22-000100.hdr.sgml : 20221123 20221123115111 ACCESSION NUMBER: 0001618921-22-000100 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20220831 FILED AS OF DATE: 20221123 DATE AS OF CHANGE: 20221123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Walgreens Boots Alliance, Inc. CENTRAL INDEX KEY: 0001618921 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 471758322 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36759 FILM NUMBER: 221414479 BUSINESS ADDRESS: STREET 1: 108 WILMOT ROAD CITY: DEERFIELD STATE: IL ZIP: 60015 BUSINESS PHONE: (847) 315-2500 MAIL ADDRESS: STREET 1: 108 WILMOT ROAD CITY: DEERFIELD STATE: IL ZIP: 60015 10-K/A 1 wba-20220831.htm 10-K/A wba-20220831
00016189212022FYtrueWBA is filing this Amendment to amend Item 15 to include the consolidated financial statements of its equity investee, AmerisourceBergen Corporation (“ABC”) as of September 30, 202200016189212021-09-012022-08-310001618921us-gaap:CommonStockMember2021-09-012022-08-310001618921wba:A3600NotesPayableDue2025Member2021-09-012022-08-310001618921wba:A3450NotesPayableDue2026Member2021-09-012022-08-3100016189212022-08-31iso4217:USDxbrli:shares



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
Amendment No. 1
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended August 31, 2022
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From ____________ to ___________
Commission file number 001-36759
WALGREENS BOOTS ALLIANCE, INC.
(Exact name of registrant as specified in its charter)
Delaware 47-1758322
(State of incorporation) (I.R.S. Employer Identification No.)
108 Wilmot Road, Deerfield, Illinois
 60015
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:  (847) 315-3700
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par valueWBAThe Nasdaq Stock Market LLC
3.600% Walgreens Boots Alliance, Inc. notes due 2025WBA25The Nasdaq Stock Market LLC
2.125% Walgreens Boots Alliance, Inc. notes due 2026WBA26The Nasdaq Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act:    None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.      Yes ☑          No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes ☐         No ☑
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).      Yes  ☑   No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
Accelerated filer ☐
 Non-accelerated filer ☐
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).          Yes           No ☑
As of February 28, 2022, the aggregate market value of Walgreens Boots Alliance, Inc. common stock held by non-affiliates (based on the closing transaction price on Friday, February 28, 2022) was approximately $23.2 billion. 
As of September 30, 2022, there were 864,813,091 shares of Walgreens Boots Alliance, Inc. common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive proxy statement for our Annual Meeting of Stockholders planned to be held on January 26, 2023 are incorporated by reference into Part III of this Form 10-K as indicated herein.




EXPLANATORY NOTE
This Amendment No. 1 to the Annual Report on Form 10-K (this “Amendment”) of Walgreens Boots Alliance, Inc. (“WBA”) amends WBA’s Annual Report on Form 10-K for the year ended August 31, 2022, which WBA filed with the Securities and Exchange Commission (“SEC”) on October 13, 2022 (the “Original Form 10-K”). WBA is filing this Amendment to amend Item 15 to include the consolidated financial statements of its equity investee, AmerisourceBergen Corporation (“ABC”) as of September 30, 2022 and 2021 and for the years ended September 30, 2022, 2021 and 2020 (the “ABC Financial Statements”) in accordance with Rule 3-09 of Regulation S-X under the Securities Exchange Act of 1934, as amended. The ABC Financial Statements, which were prepared by ABC, were audited in accordance with the standards of the Public Company Accounting Oversight Board (United States).

Except as otherwise expressly noted, this Amendment does not modify or update in any way (i) the consolidated financial position, the results of operations or cash flows of WBA, or (ii) the disclosures in the Original Form 10-K; nor does it reflect events occurring after the filing of the Original Form 10-K. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and WBA’s other filings made with the SEC subsequent to the filing of the Original Form 10-K.




Part IV

Item 15. Exhibits and financial statement schedules

(a)Documents filed as part of this report:
(1)Financial statements. The following financial statements, supplementary data and reports of independent public accountants appear in Part II, Item 8 of this Form 10-K and are incorporated herein by reference.
Consolidated Balance Sheets at August 31, 2022 and 2021
Consolidated Statements of Equity, Earnings, Comprehensive Income and Cash Flows for the years ended August 31, 2022, 2021 and 2020
Notes to Consolidated Financial Statements
Management’s Report on Internal Control
Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34), Chicago, Illinois
.
(2)Financial statement schedules and supplementary information
Schedule II is incorporated herein by reference.

Schedules I, III, IV and V are not submitted because they are not applicable or not required or because the required information is included in the Financial Statements referenced in (1) above or the notes thereto.

The financial statements of AmerisourceBergen Corporation and its consolidated subsidiaries required by Rule 3-09 of Regulation S-X are included in Item 8. Financial Statements and supplementary data on pages 50 to 89 and Schedule II on page 101 of Exhibit 99.4 to this Amendment.
 
(3)Exhibits. Exhibits 10.1 through 10.42 constitute management contracts or compensatory plans or arrangements required to be filed as exhibits pursuant to Item 15(b) of this Form 10-K.


(b)Exhibits

Exhibit
No.
Description SEC Document Reference
Purchase and Option Agreement by and among Walgreen Co., Alliance Boots GmbH and AB Acquisitions Holdings Limited dated June 18, 2012 and related annexes. Incorporated by reference to Annex B-1 to the proxy statement/prospectus forming a part of the Registration Statement on Form S-4 (File No. 333-198768) filed with the SEC pursuant to Rule 424(b)(3) on November 24, 2014.
Amendment No. 1 to Purchase and Option Agreement and Walgreen Co. Shareholders Agreement, dated August 5, 2014, by and among Walgreen Co., Alliance Boots GmbH, AB Acquisitions Holdings Limited, Walgreen Scotland Investments LP, KKR Sprint (European II) Limited, KKR Sprint (2006) Limited and KKR Sprint (KPE) Limited, Alliance Santé Participations S.A., Stefano Pessina and Kohlberg Kravis Roberts & Co. L.P. Incorporated by reference to Annex B-2 to the proxy statement/prospectus forming a part of the Registration Statement on Form S-4 (File No. 333-198768) filed with the SEC pursuant to Rule 424(b)(3) on November 24, 2014.
Agreement and Plan of Merger, dated October 17, 2014, by and among Walgreen Co., Walgreens Boots Alliance, Inc. and Ontario Merger Sub, Inc. Incorporated by reference to Annex A to the proxy statement/prospectus forming a part of the Registration Statement on Form S-4 (File No. 333-198768) filed with the SEC pursuant to Rule 424(b)(3) on November 24, 2014.



Amendment No. 1 to Agreement and Plan of Merger, dated December 23, 2014, by and among Walgreen Co., Walgreens Boots Alliance, Inc. and Ontario Merger Sub, Inc. Incorporated by reference to Exhibit 2.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on December 24, 2014.
Amendment No. 2 to Agreement and Plan of Merger, dated December 29, 2014, by and among Walgreen Co., Walgreens Boots Alliance, Inc. and Ontario Merger Sub, Inc. Incorporated by reference to Exhibit 2.3 to Walgreens Boots Alliance, Inc.’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2014 (File No. 1-36759) filed with the SEC on December 30, 2014.
Amended and Restated Asset Purchase Agreement, dated as of September 18, 2017, by and among Walgreens Boots Alliance, Inc., Walgreen Co. and Rite Aid Corporation. Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on September 19, 2017.
Share Purchase Agreement, dated as of January 6, 2021, by and between Walgreens Boots Alliance, Inc., and AmerisourceBergen Corporation.Incorporated by reference to Exhibit 2.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on January 8, 2021.
Securities Purchase Agreement, by and among Walgreen Co., the several equity holders of Shields Health Solutions Parent, LLC listed on Schedules A and B thereto, the stockholders of WCAS Shields Holdings, Inc. listed on Schedule C thereto, Shields Health Solutions Parent, LLC, WCAS Shields Holdings, Inc. and WCAS XIII Associates, LLC, solely in its capacity as Sellers’ Representative thereunder.Incorporated by reference to Exhibit 2.1 to Walgreen’s Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on September 21, 2021.
Class D Preferred Unit Purchase Agreement, dated as of October 14, 2021, by and among WBA Acquisition 4, LLC, WBA Financial, LLC, Walgreens Boots Alliance, Inc., Village Practice Management Company, LLC and certain members of Village Practice Management Company, LLCIncorporated by reference to Exhibit 2.1 to Walgreen’s Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on October 14, 2021.
Securities Purchase Agreement and Agreement and Plan of Merger, dated September 19, 2022, by and among WBA Acquisition 4, LLC, Walgreen Co., WBA Shields Merger Sub, LLC, certain equityholders of WCAS Shields Holdings, LLC listed on Schedule A thereto, WCAS Shields Holdings, LLC, Shields Health Solutions Parent, LLC and WCAS XIII Associates, LLC, solely in its capacity as Sellers’ Representative thereunderIncorporated by reference to Exhibit 2.1 to Walgreen’s Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on September 20, 2022.
Amended and Restated Certificate of Incorporation of Walgreens Boots Alliance, Inc.
 
 Incorporated by reference to Exhibit 3.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K12B (File No. 1-36759) filed with the SEC on December 31, 2014.
Amended and Restated By-laws of Walgreens Boots Alliance, Inc. Incorporated by reference to Exhibit 3.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on June 10, 2016.
4.1**
Indenture, dated as of July 17, 2008, between Walgreen Co. and Wells Fargo Bank, National Association, as trustee. Incorporated by reference to Exhibit 4.3 to Walgreen Co.’s registration statement on Form S-3ASR (File No. 333-152315) filed with the SEC on July 14, 2008.
Form of Walgreen Co. 4.400% Note due 2042. Incorporated by reference to Exhibit 4.5 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on September 13, 2012.



Form of Guarantee of Walgreens Boots Alliance, Inc. Incorporated by reference to Exhibit 4.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K12B (File No. 1-36759) filed with the SEC on December 31, 2014.
Indenture dated November 18, 2014 among Walgreens Boots Alliance, Inc. and Wells Fargo Bank, National Association, as trustee. Incorporated by reference to Exhibit 4.1 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on November 18, 2014.
Form of 3.800% Notes due 2024. Incorporated by reference to Exhibit 4.6 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on November 18, 2014.
Form of 4.500% Notes due 2034. Incorporated by reference to Exhibit 4.7 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on November 18, 2014.
Form of 4.800% Notes due 2044. Incorporated by reference to Exhibit 4.8 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on November 18, 2014.
Form of 3.600% Notes due 2025 (£). Incorporated by reference to Exhibit 4.3 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on November 20, 2014.
Form of 2.125% Notes due 2026 (€). Incorporated by reference to Exhibit 4.4 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on November 20, 2014.
Indenture, dated as of December 17, 2015, between Walgreens Boots Alliance, Inc. and Wells Fargo Bank, National Association, as trustee. Incorporated by reference to Exhibit 4.1 to the Registration Statement on Form S-3 (File No. 333-208587) filed with the SEC on December 17, 2015.
First Supplemental Indenture, dated as of October 13, 2021, by and between Walgreens Boots Alliance, Inc. and Wells Fargo Bank, National Association, as trustee.Incorporated by reference to Exhibit 4.13 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2021 (File No. 1-36759) filed with the SEC on October 14, 2021.
Form of 3.450% Notes due 2026. Incorporated by reference to Exhibit 4.5 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on June 1, 2016.
Form of 4.650% Notes due 2046. Incorporated by reference to Exhibit 4.6 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on June 1, 2016.
Form of 3.200% Notes due 2030.Incorporated by reference to Exhibit 4.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on April 15, 2020.
Form of 4.100% Notes due 2050. Incorporated by reference to Exhibit 4.2 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on April 15, 2020.
Form of 0.950% Notes due 2023.Incorporated by reference to Exhibit 4.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on November 17, 2021.
Walgreen Co. Shareholders Agreement, dated as of August 2, 2012, among Walgreen Co., Stefano Pessina, KKR Sprint (European II) Limited, KKR Sprint (2006) Limited and KKR Sprint (KPE) Limited, Alliance Santé Participations S.A., Kohlberg Kravis Roberts & Co. L.P. and certain other investors party thereto. Incorporated by reference to Exhibit 4.1 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on August 6, 2012.



Letter Agreement between Stefano Pessina and Walgreens Boots Alliance, Inc., dated July 23, 2020.Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on July 27, 2020.
Amendment No. 1 to Purchase and Option Agreement and Walgreen Co. Shareholders Agreement, dated August 5, 2014, by and among Walgreen Co., Alliance Boots GmbH, AB Acquisitions Holdings Limited, Walgreen Scotland Investments LP, KKR Sprint (European II) Limited, KKR Sprint (2006) Limited and KKR Sprint (KPE) Limited, Alliance Santé Participations S.A., Stefano Pessina and Kohlberg Kravis Roberts & Co. L.P.
 Incorporated by reference to Annex B-2 to the proxy statement/prospectus forming a part of the Registration Statement on Form S-4 (File No. 333-198768) filed with the SEC pursuant to Rule 424(b)(3) on November 24, 2014.
Amendment No. 2 to Purchase and Option Agreement and Walgreen Co. Shareholders Agreement, dated December 31, 2014, as Amended by Amendment No.1, dated as of August 5, 2014, by and among Walgreen Co., Alliance Boots GmbH, AB Acquisitions Holdings Limited, Ontario Holdings WBS Limited, KKR Sprint (European II)Limited, KKR Sprint (2006) Limited and KKR Sprint (KPE) Limited, Alliance Santé Participations S.A., Stefano Pessina and Kohlberg Kravis Roberts & Co. L.P. Incorporated by reference to Exhibit E to the Schedule 13D filed by Alliance Santé Participations S.A. (File No. 005-88481) filed with the SEC on December 31, 2014).
Description of Registered Securities.Filed herewith.***
Walgreens Boots Alliance, Inc. Management Incentive Plan (as amended and restated effective July 1, 2016).
 Incorporated by reference to Exhibit 10.2 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2016 (File No. 1-36759) filed with the SEC on October 20, 2016.
Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan.Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on February 2, 2021.
Form of Performance Share Award agreement (effective October 2021).
Incorporated by reference to Exhibit 10.4 to Walgreens Boots Alliance, Inc.’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2021 (File No. 1-36759) filed with the SEC on January 6, 2022.
Form of Performance Share Award agreement (effective January 2021).Incorporated by reference to Exhibit 10.2 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on February 2, 2021.
Form of Stock Option Award agreement (effective October 2021).Incorporated by reference to Exhibit 10.5 to Walgreens Boots Alliance, Inc.’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2021 (File No. 1-36759) filed with the SEC on January 6, 2022.
Form of Stock Option Award agreement (effective January 2021).Incorporated by reference to Exhibit 10.3 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on February 2, 2021.
Form of Restricted Stock Unit Award agreement (effective October 2021).Incorporated by reference to Exhibit 10.6 to Walgreens Boots Alliance, Inc.’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2021 (File No. 1-36759) filed with the SEC on January 6, 2022.
Form of Restricted Stock Unit Award agreement (effective January 2021).Incorporated by reference to Exhibit 10.4 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on February 2, 2021.



Form of Restricted Stock Unit Award agreement.Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on April 26, 2021.
Form of Restricted Stock Unit Award agreement for Executive Chairman (November 2021).Incorporated by reference to Exhibit 10.7 to Walgreens Boots Alliance, Inc.’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2021 (File No. 1-36759) filed with the SEC on January 6, 2022.
Amendment to the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan.Incorporated by reference to Exhibit 10.5 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on February 2, 2021.
Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (as amended and restated).Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on January 19, 2018.
Form of Performance Share Award agreement (effective October 2020).Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on October 30, 2020.
Form of Performance Share Award agreement (effective October 2019).Incorporated by reference to Exhibit 10.3 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2019 (File No. 1-36759) filed with the SEC on October 28, 2019.
Form of Stock Option Award agreement (effective October 2020).Incorporated by reference to Exhibit 10.2 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on October 30, 2020.
Form of Stock Option Award agreement (effective October 2019).Incorporated by reference to Exhibit 10.6 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2019 (File No. 1-36759) filed with the SEC on October 28, 2019.
Form of Restricted Stock Unit Award agreement (effective October 2020).Incorporated by reference to Exhibit 10.4 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on October 30, 2020.
Form of Restricted Stock Unit Award agreement (effective October 2019).

 Incorporated by reference to Exhibit 10.20 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2019 (File No. 1-36759) filed with the SEC on October 28, 2019.
Form of Performance Share Award agreement for CEO (November 2019).Incorporated by reference to Exhibit 10.10 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2019 (File No. 1-36759) filed with the SEC on October 28, 2019.
Form of Stock Option Award agreement for CEO (November 2019). Incorporated by reference to Exhibit 10.14 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2019 (File No. 1-36759) filed with the SEC on October 28, 2019.
Form of Restricted Stock Unit Award agreement for CEO (November 2019).Incorporated by reference to Exhibit 10.18 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2019 (File No. 1-36759) filed with the SEC on October 28, 2019.
Form of Amendment to Stock Option Award agreements. Incorporated by reference to Exhibit 10.11 to Walgreen Co.’s Annual Report on Form 10-K for the fiscal year ended August 31, 2014 (File No. 1-00604) filed with the SEC on October 20, 2014.



Amendments to certain Omnibus Plan Award agreements (October 2018).Incorporated by reference to Exhibit 10.7 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on October 26, 2018.
UK Sub-Plan under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan. Incorporated by reference to Exhibit 10.16 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K (File No. 1-36759) filed with the SEC on October 28, 2015.
Form of Stock Option Award agreement under UK Sub-plan (effective October 2020).Incorporated by reference to Exhibit 10.3 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on October 30, 2020.
Form of Stock Option Award agreement under UK Sub-plan (effective October 2019).Incorporated by reference to Exhibit 10.29 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2019 (File No. 1-36759) filed with the SEC on October 28, 2019.
Form of Stock Option Award agreement under UK Sub-plan (effective October 2018).Incorporated by reference to Exhibit 10.4 to Walgreens Boots Alliance, Inc.’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2018 (File No. 1-36759) filed with the SEC on December 20, 2018.
Walgreen Co. Executive Stock Option Plan (as amended and restated effective January 13, 2010).
 Incorporated by reference to Exhibit 99.1 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on January 20, 2010.
Walgreen Co. 2002 Executive Deferred Compensation/Capital Accumulation Plan. Incorporated by reference to Exhibit 10(g) to Walgreen Co.’s Annual Report on Form 10-K for the fiscal year ended August 31, 2002 (File No. 1-00604).
Amendment to the Walgreen Co. 2002 et. al. Executive Deferred Compensation/Capital Accumulation Plans. Incorporated by reference to Exhibit 10.3 to Walgreen Co.’s Quarterly Report on Form 10-Q for the fiscal quarter ended February 28, 2009 (File No. 1-00604).
Walgreen Co. 2006 Executive Deferred Compensation/Capital Accumulation Plan (effective January 1, 2006).
 Incorporated by reference to Exhibit 10(b) to Walgreen Co.’s Quarterly Report on Form 10-Q for the fiscal quarter ended November 30, 2005
(File No. 1-00604).
Walgreens Boots Alliance, Inc. Executive Retirement Savings Plan (as amended and restated effective January 1, 2020).Incorporated by reference to Exhibit 10.43 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2019 (File No. 1-36759) filed with the SEC on October 28, 2019.
First Amendment to the Walgreens Boots Alliance, Inc. Executive Retirement Savings Plan (as amended and restated effective January 1, 2020).Incorporated by reference to Exhibit 10.38 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2021 (File No. 1-36759) filed with the SEC on October 14, 2021.
Walgreens Boots Alliance, Inc. Executive Severance and Change in Control Plan (as amended and restated effective August 6, 2019).Incorporated by reference to Exhibit 10.47 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2019 (File No. 1-36759) filed with the SEC on October 28, 2019.
Offer Letter agreement between Stefano Pessina and Walgreens Boots Alliance, Inc. Incorporated by reference to Exhibit 10.29 to Walgreens Boots Alliance, Inc.’s Quarterly Report on Form 10-Q for the quarter ended February 28, 2015 (File No. 1-36759) filed with the SEC on April 9, 2015.
Offer Letter agreement between Walgreens Boots Alliance, Inc. and Rosalind G. Brewer dated January 26, 2021. Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on February 1, 2021.



Offer Letter agreement dated as of March 6, 2018 between James Kehoe and Walgreens Boots Alliance, Inc.
Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on March 8, 2018.
Offer Letter agreement dated as of August 27, 2020 between John Standley and Walgreens Boots Alliance, Inc.Incorporated by reference to Exhibit 10.46 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K for the year ended August 31, 2021 (File No. 1-36759) filed with the SEC on October14, 2021.
Employment Agreement between Alliance UniChem Plc and Ornella Barra dated December 10, 2002.Incorporated by reference to Exhibit 10.20 to Walgreens Boots Alliance, Inc.’s Quarterly Report on Form 10-Q for the quarter ended February 28, 2015 (File No. 1-36759) filed with the SEC on April 9, 2015.
Agreement among Alliance Boots plc, Alliance UniChem Plc and Ornella Barra, dated July 31, 2006.Incorporated by reference to Exhibit 10.21 to Walgreens Boots Alliance, Inc.’s Quarterly Report on Form 10-Q for the quarter ended February 28, 2015 (File No. 1-36759) filed with the SEC on April 9, 2015.
Novation of Service Agreement among Alliance Boots Holdings Limited, Alliance Boots Management Services MC S.A.M and Ornella Barra, dated June 1, 2013.Incorporated by reference to Exhibit 10.22 to Walgreens Boots Alliance, Inc.’s Quarterly Report on Form 10-Q for the quarter ended February 28, 2015 (File No. 1-36759) filed with the SEC on April 9, 2015.
Walgreens Boots Alliance, Inc. Long-Term Global Assignment Relocation Policy.Incorporated by reference to Exhibit 10.68 to Walgreens Boots Alliance, Inc.’s Annual Report on Form 10-K (File No. 1-36759) filed with the SEC on October 28, 2015.
Secondment Agreement dated September 27, 2013 between Alliance Boots Management Services Limited and Walgreen Co.Incorporated by reference to Exhibit 10.52 to Walgreen Co.’s Annual Report on Form 10-K for the fiscal year ended August 31, 2013 (File No. 1-00604).
Shareholders’ Agreement, dated as of August 2, 2012, by and among Alliance Boots GmbH, AB Acquisition Holdings Limited and Walgreen Co.Incorporated by reference to Exhibit 10.1 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on August 6, 2012.
Framework Agreement, dated as of March 18, 2013, by and among Walgreen Co., Alliance Boots GmbH and AmerisourceBergen Corporation.Incorporated by reference to Exhibit 10.1 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on March 20, 2013.
Shareholders Agreement, dated as of March 18, 2013, by and among Walgreen Co., Alliance Boots GmbH and AmerisourceBergen Corporation.Incorporated by reference to Exhibit 10.2 to Walgreen Co.’s Current Report on Form 8-K (File No. 1-00604) filed with the SEC on March 20, 2013.
Amended and Restated AmerisourceBergen Shareholders Agreement, dated as of June 1, 2021, between AmerisourceBergen Corporation and Walgreens Boots Alliance, Inc.Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on June 4, 2021.
Second Amended and Restated Limited Liability Company Agreement of Shields Health Solutions Parent, LLC.Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on October 29, 2021.
Seventh Amended and Restated Limited Liability Company Agreement of Village Practice Management Company, LLC.Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on November 26, 2021.
Appointment and Waiver Agreement, dated as of November 24, 2021, by and among Walgreens Boots Alliance, Inc., WBA Acquisition 5, LLC and Village Practice Management Company, LLC.Incorporated by reference to Exhibit 10.2 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on November 26, 2021.



Delayed Draw Term Loan Credit Agreement, dated as of November 15, 2021, by and among Walgreens Boots Alliance, Inc., the Designated Borrowers from time to time party thereto, the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent.Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance Inc.’s Current Report on Form 8-K (File No. 1-36759) filed on November 16, 2021.
5-Year Revolving Credit Facility, dated as of June 17, 2022, by and among Walgreens Boots Alliance, Inc., the Designated Borrowers from time to time party thereto, the Lenders and L/C Issuers from time to time party thereto and Wells Fargo Bank, National Association, as Administrative Agent.Incorporated by reference to Exhibit 10.1 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on June 21, 2022.
18-Month Revolving Credit Facility, dated as of June 17, 2022, by and among Walgreens Boots Alliance, Inc., the Designated Borrowers from time to time party thereto, the Lenders from time to time party thereto and Wells Fargo Bank, National Association, as Administrative Agent.Incorporated by reference to Exhibit 10.2 to Walgreens Boots Alliance, Inc.’s Current Report on Form 8-K (File No. 1-36759) filed with the SEC on June 21, 2022.
Subsidiaries of the Registrant. Filed herewith.***
Consent of Deloitte & Touche LLP.
 Filed herewith.***
Consent of Ernst & Young LLP.Filed herewith.
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Filed herewith.
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Filed herewith.
Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. Furnished herewith.
Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. Furnished herewith.
AmerisourceBergen Corporation consolidated financial statements and schedule as of September 30, 2022 and 2021 and for the years ended September 30, 2022, 2021 and 2020; and Independent Registered Public Accounting Firms’ Reports as of September 30, 2022 and 2021 and for the years ended September 30, 2022, 2021 and 2020.
Incorporated by reference to Item 8. Financial Statements and supplementary data on pages 50 to 89 and Schedule II on page 101 to AmerisourceBergen’s Annual Report on Form 10-K for the year ended September 30, 2022.
101.INSXBRL Instance Document (The following financial information from this Annual Report on Form 10-K for the fiscal year ended August 31, 2022 formatted in Inline XBRL (Extensive Business Reporting Language) includes: (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Equity; (iii) the Consolidated Statement of Earnings; (iv) the Consolidated Statements of Comprehensive Income; (v) the Consolidated Statements of Cash Flows; and (vi) Notes to Financial Statements). Filed herewith.***
101.SCHXBRL Taxonomy Extension Schema Document Filed herewith.***
101.CALXBRL Taxonomy Extension Calculation Linkbase Document Filed herewith.***
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document Filed herewith.***
101.LAB
XBRL Taxonomy Extension Label Linkbase Document Filed herewith.***



101.PREXBRL Taxonomy Extension Presentation Linkbase Document Filed herewith.***
104Cover Page Interactive Data File (formatted as Inline XBRL document and included in Exhibit 101)Filed herewith.

*Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Copies of any omitted schedule or exhibit will be furnished supplementally to the SEC upon request.

**Other instruments defining the rights of holders of long-term debt of the registrant and its consolidated subsidiaries may be omitted from Exhibit 4 in accordance with Item 601(b)(4)(iii)(A) of Regulation S-K. Copies of any such agreements will be furnished supplementally to the SEC upon request.

*** Previously filed or furnished, as applicable, with the Original Form 10-K on October 13, 2022.









SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 WALGREENS BOOTS ALLIANCE, INC.
  
November 23, 2022By:/s/ James Kehoe
 
          James Kehoe
           Executive Vice President and Global Chief Financial Officer

EX-23.2 2 a232eyconsent10-ka.htm EX-23.2 Document

Exhibit 23.2


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:
1.Registration Statement (Form S-3 No. 333-261730) of Walgreens Boots Alliance, Inc, and
2.Registration Statement (Form S-8 Nos. 333-201327, 333-198768, and 333-252782) pertaining to the Walgreens Boots Alliance, Inc. 2021 and 2013 Omnibus Incentive Plan;

of our report dated November 22, 2022, with respect to the consolidated financial statements and schedule of AmerisourceBergen Corporation and subsidiaries incorporated by reference in this Annual Report (Form 10-K/A) of Walgreens Boots Alliance, Inc. for the year ended August 31, 2022.

/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
November 23, 2022

EX-31.1 3 a4q22exhibit311.htm EX-31.1 Document





EXHIBIT 31.1


CERTIFICATION

I, Rosalind G. Brewer, certify that:

1.I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Walgreens Boots Alliance, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;    
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

/s/ Rosalind G. BrewerChief Executive OfficerDate: November 23, 2022
Rosalind G. Brewer


EX-31.2 4 a4q22exhibit312.htm EX-31.2 Document






EXHIBIT 31.2



CERTIFICATION

I, James Kehoe, certify that:

1.I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Walgreens Boots Alliance, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;    
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

/s/ James Kehoe
Global Chief Financial OfficerDate: November 23, 2022
James Kehoe


EX-32.1 5 a4q22exhibit321.htm EX-32.1 Document




Exhibit 32.1



CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)


In connection with the Amendment No. 1 to the Annual Report of Walgreens Boots Alliance, Inc., a Delaware corporation (the "Company"), on Form 10-K for the year ended August 31, 2022 as filed with the Securities and Exchange Commission (the "Report"), I, Rosalind G. Brewer, Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Rosalind G. Brewer
______________________________
Rosalind G. Brewer
Chief Executive Officer
Dated: November 23, 2022


EX-32.2 6 a4q22exhibit322.htm EX-32.2 Document




Exhibit 32.2


CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)


In connection with the Amendment No. 1 to the Annual Report of Walgreens Boots Alliance, Inc., a Delaware corporation (the "Company"), on Form 10-K for the year ended August 31, 2022 as filed with the Securities and Exchange Commission (the "Report"), I, James Kehoe, Global Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ James Kehoe
__________________________
James Kehoe
Global Chief Financial Officer
Dated: November 23, 2022


EX-101.SCH 7 wba-20220831.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 8 wba-20220831_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 wba-20220831_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Auditor name Auditor Name Entity Address, Address Line One Entity Address, Address Line One Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Entity Shell Company Entity Shell Company Trading Symbol Trading Symbol Entity File Number Entity File Number 3.600% Walgreens Boots Alliance, Inc. notes due 2025 3.600% Notes Payable, Due 2025 [Member] A written promise to pay a note to a third party. Auditor location Auditor Location Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Document Fiscal Year Focus Document Fiscal Year Focus Entity Public Float Entity Public Float Entity Filer Category Entity Filer Category Entity Address, Postal Zip Code Entity Address, Postal Zip Code Class of Stock [Domain] Class of Stock [Domain] Document Fiscal Period Focus Document Fiscal Period Focus City Area Code City Area Code Document Information [Line Items] Document Information [Line Items] Entity Interactive Data Current Entity Interactive Data Current Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Current Fiscal Year End Date Current Fiscal Year End Date Document Period End Date Document Period End Date Document Annual Report Document Annual Report Entity Tax Identification Number Entity Tax Identification Number ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Common Stock, $0.01 par value Common Stock [Member] Auditor firm ID Auditor Firm ID Amendment Description Amendment Description Entity Current Reporting Status Entity Current Reporting Status Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Address, City or Town Entity Address, City or Town Class of Stock [Axis] Class of Stock [Axis] Document Transition Report Document Transition Report Local Phone Number Local Phone Number Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Cover [Abstract] Entity Voluntary Filers Entity Voluntary Filers 2.125% Walgreens Boots Alliance, Inc. notes due 2026 3.450% Notes Payable, Due 2026 [Member] A written promise to pay a note to a third party. Document Type Document Type Audit Information [Abstract] Audit Information Document Information [Table] Document Information [Table] Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province EX-101.PRE 10 wba-20220831_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover Page
12 Months Ended
Aug. 31, 2022
USD ($)
shares
Document Information [Line Items]  
Document Type 10-K/A
Document Annual Report true
Document Period End Date Aug. 31, 2022
Current Fiscal Year End Date --08-31
Document Transition Report false
Entity File Number 001-36759
Entity Registrant Name WALGREENS BOOTS ALLIANCE, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 47-1758322
Entity Address, Address Line One 108 Wilmot Road
Entity Address, City or Town Deerfield
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60015
City Area Code 847
Local Phone Number 315-3700
Entity Well-known Seasoned Issuer Yes
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
ICFR Auditor Attestation Flag true
Entity Shell Company false
Entity Public Float | $ $ 23,200,000,000
Entity Common Stock, Shares Outstanding (in shares) | shares 864,813,091
Documents Incorporated by Reference Portions of the definitive proxy statement for our Annual Meeting of Stockholders planned to be held on January 26, 2023 are incorporated by reference into Part III of this Form 10-K as indicated herein.
Entity Central Index Key 0001618921
Document Fiscal Year Focus 2022
Document Fiscal Period Focus FY
Amendment Flag true
Amendment Description WBA is filing this Amendment to amend Item 15 to include the consolidated financial statements of its equity investee, AmerisourceBergen Corporation (“ABC”) as of September 30, 2022
Common Stock, $0.01 par value  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, $0.01 par value
Trading Symbol WBA
Security Exchange Name NASDAQ
3.600% Walgreens Boots Alliance, Inc. notes due 2025  
Document Information [Line Items]  
Title of 12(b) Security 3.600% Walgreens Boots Alliance, Inc. notes due 2025
Trading Symbol WBA25
Security Exchange Name NASDAQ
2.125% Walgreens Boots Alliance, Inc. notes due 2026  
Document Information [Line Items]  
Title of 12(b) Security 2.125% Walgreens Boots Alliance, Inc. notes due 2026
Trading Symbol WBA26
Security Exchange Name NASDAQ
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Audit Information
12 Months Ended
Aug. 31, 2022
Audit Information [Abstract]  
Auditor firm ID 34
Auditor location Chicago, Illinois
Auditor name Deloitte & Touche LLP.
XML 13 wba-20220831_htm.xml IDEA: XBRL DOCUMENT 0001618921 2021-09-01 2022-08-31 0001618921 us-gaap:CommonStockMember 2021-09-01 2022-08-31 0001618921 wba:A3600NotesPayableDue2025Member 2021-09-01 2022-08-31 0001618921 wba:A3450NotesPayableDue2026Member 2021-09-01 2022-08-31 0001618921 2022-08-31 iso4217:USD shares 0001618921 2022 FY true WBA is filing this Amendment to amend Item 15 to include the consolidated financial statements of its equity investee, AmerisourceBergen Corporation (“ABC”) as of September 30, 2022 10-K/A true 2022-08-31 --08-31 false 001-36759 WALGREENS BOOTS ALLIANCE, INC. DE 47-1758322 108 Wilmot Road Deerfield IL 60015 847 315-3700 Common Stock, $0.01 par value WBA NASDAQ 3.600% Walgreens Boots Alliance, Inc. notes due 2025 WBA25 NASDAQ 2.125% Walgreens Boots Alliance, Inc. notes due 2026 WBA26 NASDAQ Yes No Yes Yes Large Accelerated Filer false false true false 23200000000 864813091 Portions of the definitive proxy statement for our Annual Meeting of Stockholders planned to be held on January 26, 2023 are incorporated by reference into Part III of this Form 10-K as indicated herein. 2022-08-31 --08-31 34 Chicago, Illinois Deloitte & Touche LLP. EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 16 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 17 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 5 38 1 false 3 0 false 2 false false R1.htm 0000001 - Document - Cover Page Sheet http://walgreensbootsalliance.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://walgreensbootsalliance.com/role/AuditInformation Audit Information Cover 2 false false All Reports Book All Reports wba-20220831.htm a232eyconsent10-ka.htm a4q22exhibit311.htm a4q22exhibit312.htm a4q22exhibit321.htm a4q22exhibit322.htm wba-20220831.xsd wba-20220831_def.xml wba-20220831_lab.xml wba-20220831_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 19 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "wba-20220831.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 5, "dts": { "definitionLink": { "local": [ "wba-20220831_def.xml" ] }, "inline": { "local": [ "wba-20220831.htm" ] }, "labelLink": { "local": [ "wba-20220831_lab.xml" ] }, "presentationLink": { "local": [ "wba-20220831_pre.xml" ] }, "schema": { "local": [ "wba-20220831.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 47, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 5, "total": 5 }, "keyCustom": 0, "keyStandard": 38, "memberCustom": 2, "memberStandard": 1, "nsprefix": "wba", "nsuri": "http://walgreensbootsalliance.com/20220831", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wba-20220831.htm", "contextRef": "i0c99ee739870494881b98fb96b70b064_D20210901-20220831", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "role": "http://walgreensbootsalliance.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wba-20220831.htm", "contextRef": "i0c99ee739870494881b98fb96b70b064_D20210901-20220831", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wba-20220831.htm", "contextRef": "i0c99ee739870494881b98fb96b70b064_D20210901-20220831", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "0000002 - Document - Audit Information", "role": "http://walgreensbootsalliance.com/role/AuditInformation", "shortName": "Audit Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "wba-20220831.htm", "contextRef": "i0c99ee739870494881b98fb96b70b064_D20210901-20220831", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description", "terseLabel": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/AuditInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "verboseLabel": "Common Stock, $0.01 par value" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "wba_A3450NotesPayableDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A written promise to pay a note to a third party.", "label": "3.450% Notes Payable, Due 2026 [Member]", "verboseLabel": "2.125% Walgreens Boots Alliance, Inc. notes due 2026" } } }, "localname": "A3450NotesPayableDue2026Member", "nsuri": "http://walgreensbootsalliance.com/20220831", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "wba_A3600NotesPayableDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A written promise to pay a note to a third party.", "label": "3.600% Notes Payable, Due 2025 [Member]", "verboseLabel": "3.600% Walgreens Boots Alliance, Inc. notes due 2025" } } }, "localname": "A3600NotesPayableDue2025Member", "nsuri": "http://walgreensbootsalliance.com/20220831", "presentation": [ "http://walgreensbootsalliance.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "wba_AuditInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Information", "label": "Audit Information [Abstract]" } } }, "localname": "AuditInformationAbstract", "nsuri": "http://walgreensbootsalliance.com/20220831", "xbrltype": "stringItemType" } }, "unitCount": 2 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r4": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r5": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r6": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r7": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r8": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r9": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" } }, "version": "2.1" } ZIP 20 0001618921-22-000100-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001618921-22-000100-xbrl.zip M4$L#!!0 ( &1>=U6C+=B-S , %\- 6 83(S,F5Y8V]N3T;0\MR MG-M@[#B3]01^77^YAH[M>K!61&AFF!2$.\YTWH)69DPQ<)SM=FMO UNJU%FO MG$I5Q^%2:FK')FZ=CZI_\*8D/O]I],ZR8"*C,J?"0*0H,32&4C.1PFU,]1U8 MUIYK+(N=8FEFP'=]'VZENF,;TM -,YR>'_2,G.9YY-1&1J&,=^>CF&V Q9]: M+':3A'3/^O0L))U>U^OC<:/0CWK]CM\)P]\]=-)!]D9&FQVGGUHY$U9&*_N# MGE^8X9;%)AMXKOMSZR$?42FRAM(8F0]22S4X<>LSK"A60G+&=X/W:Y93#7.ZA97,B7C?UI@@2U/% MDH91LS\H.HR^UX_;)I@.ZN%,T$-P3433[QD+&4(=V/Y#CY_V-4+8J3H>YXM) M_7_ >/\ IO?)VO M9_//<#5;?3D:V,-Z.7NN6!Y+&5E4)=8MCM1)4)^7J9-N!<X'X F< MX:FB5&BXE-)HN."<$\.;=@RDR&3+FCTU^"JYICDK)%)F$"$&.$8 MP&$LU1CI**-QR6G5'ASHT0!Q6:+X:),2VT@\)K@ M[1]\$SV[MOR U($>DN@N5;(4L;4O@J0^P]=:96KP='W#5 F$XO0DP/?+-_0I MA>OKY=L-;9DQ3F+*BXR1-BRI$'K'-T0P\A9B>GK!NN_6H"G8HZ'\?1LO9/,M M,E"4DVIJ'=W/#XOYO0@)L>]+G#1 FF1WC=M+%X$/O?MTH$7*)D*)6I*RX_WU]PPEQW;L MM,ZVV#B+RP?%$H?#XF93K1N/ZIL(J$^^S?J,QF\WJLT[=V'%C M>-L@5=V&-L;)NO"BR'6HU=F2A/9.I99"7W4K#\Z;H=:+XORT8V8!XT[[?I1+_.G,R7\I-]J-O]>":+G9[%)/<:SZ%_\+-1L*//RWM>X M5N.T'Z94>;+KJ^^T:(Z,-K;_IAG^3JFE%O-$Z7G_W5 ETK$;.6.W)N'INZH# MM&I.6A47@D[]+N%GN#SWPX'/PXN+X:#3S<;UKZ,3>P).W;PJ$H%O-D_R5X*9H,JM#@$-A7L MISK[:.5,VBJ+I/4JGC,_X?[MF][QZ1^:8L:% /6M(Q]OWT$@U8G7:,G+S3M M5GUA])\_^NF:6UHG]1ZY8< F?"J9E5.%$ AX7CEV@30@0DJY,7768M[@N607 M:9ISS6YE9JQG)F4_&INP5K/V#V9B]IGKL94R=>RC,1Y*M%8\C625#=*HCFB> M;$9S_R/6WKN(?>0.<8+WDSF[2\U,2S&&DT/@;!$:86!":E 18 2N4L;3.13HGG%Z6-@- M*ZLKH',+8S:L?:U4U]T[? W7@O'.E=@IJP0B!1/'"K<'[GV(T8!Q*P,:$%TU MTI*BQB0@.-+*3:@'B27@1.)%NA?*1=JX'/V(+:W1!2PR:R(I\-BQ Z! 2,"J M"/7U?33AZ1CY$$1TFVM(M#J\UNH=R,**5D\4=\6MHKHU+>!(^AFQU0I*"]20 M+5\;:#%.O#9.C'%HFH^A"PG*[=OKJ*UP['4?P[%U_&)PY._W!H[->KM+?KB2 M#CL1!"=DK:\CITH)->*YV[T+9;:1! K*D8I<:7(+!2">J7*!SB"%2HOT4*F\ M),)5,K52\P"K,EDNL5$MB98:%4@1MCBCE0BG!RX?.244MXHFH(J4'N@])4VY MHS0;%J(+.3F0GW$2!GF0+77*./ 0:-[A=O1WN#VI'YXM G;G>EH [V[$]G.( ;PITH0-KDS*2?&Y@ZXID*1 M ,NM6( '<%9\I+3RD$#R6B1&2T1$D$Y7: 52TEE2 *O%:_1WN#U@6>OIUSG@8PH MFC*.4=NI*>+@MM1H* MVH-7B=GO!%I")CJ!$5Y2%(Y/[I\?>A?CY@[2DFC?^ M^G:%C1;5=%ALLO ![ G H@%>(;C$WH#K@0R+X&V"@/;(9;T56AYA[!GD1QG9 M1%%N*<@KZ6]-7V*; C'0"BHZ)%<:28V,#)LYFF? M'TYH"EO>%Y9,N'NH#XC$ J*E".P>9E\R[QQ;]CNIRYW](_GJ-SCDF?C=JSU1 M[Z^P)PHG?&*!^^J2:(CW5G&XY!S"TS,*A8T*$W9QU)?>6/>0E<,#*$L2Y;V4 M6YE\9)#QJ44HV!2Z'P"G($Y'Q(S_5-\N%I3\+5G9YDF"'\[L,TR@SP-8SJ=>< M??=O*W*!)!M;,$$5\96!N8"0<-);0JE:9"V53HV>2DI=*1^7!]:V)#N99-K, M)5IG$U/0&U\#*H#UC5F\_NUOGIKA-3="[\.^IA09 8C2UA $S3,G^XL?IR#H M3/-Y7Z7!E:'3*4 Z5FEM9+PW29_>FD^)Z%$%E&]% ]2*YO*%^LE)_:AY1._4 M/2SU8C%P^;J]'EZW-[S8T@:+CPZ?;&[66T]W_8+:]G&]W>Z](K6=H^Y.:AO! MP863$4:7\?1#I5-Y!(9^D[4"#!;ZOB#:SNY)^'3EM3=!Z7'0BWC_^:02/M5X M^Z9[=.K"=EL?-D6?A?;[;W?-Z7$R5C=GTOHYPVA.Q346;]=2=\!48. MQ11C-Z#)9 2F;'>JX?NAM5E_OW50DJ,W69\<%0XEV6*FK]2-?VB-[.2([^70 M-3TAF(V0?;9]QE7D(])WN.[WM<]SOIPE'WT'EIGB0[A^<6 ]E1M?ABUG$])@ M<]F%CS"EW&]V^7X%3IHDS(U'O MLBT[GG%LIZ?>U;GQJ)/V4P_N-7 MUHD:338T/+/229UQ5:_?W%989>)K4E=86(N%$ MY>*O]IHI%U% ]]K)LK>%-)95:; (W?[[2BXV[N MSF92N$F_V6C\M>)%+\X3G3DF49Z^J%O%8LV!D$@2M_ ,P.!@G M?SLK8X=ZE,Q@$V[? _1N2"^4$3<'5S M-QR\&UQ=#@?O;[_>$YD)]*)_FO^H0 ZJ[.^<]/T"$PU5%H-Q,IDS-^'NY8ON MR=E7^99S(9"1:@H2UV\=HR7KWM;HR0_RMQDMC/[^HY\]F);F:=2E:1BP"9\" M,S"5,$,N=Q-IV272LO 4?ZLCUF1.XW-@EUE6<,7N(-?&,9VQ=]JDK-FH_<)T MPCYP-38 F65OM7:H1"G)LQBC.LCB"*-YNAW-PX]8Z^ B]I9;C!/.?CIG]YF> M*1!CG&0?.!-"(S2:D&G,T#@"EQGCV9P5F3,%H >8LWUL,6:&$N=%I\)- :'5#[WXQ@D$$N#N1[%$ \6 M+1%@V&PBXPFS!5U6_6=@H%1"#J32*BP*J+Z823=!!VT.L5L@,D?3M$ WI]A- ML-%\?1H\Y%Z^:/8:.Z[/$(KMYP-%8(G,,-B$FU5PJXA#%,=FL]8NLP1IA%-I MBK]C50C4B0!:BV05P2>-FK,V=<^1@/@T8'3E2 %%C0%"<*2DG5 /$DN1$XD7 MZ5Y(&RMM"^Q';&FT"K#(C8Y!X&/+CA % A!6(=0W'^,)S\:8#Y&([@J%$LTV MKS6[1Q"L:'9%N NWD@K%+,"1]#-BJS64!M20+5\::#%.\F"ABQ*4 MVW?743OAV.ULPK%Y\L/@R%\?#!P;4:M#\W -%DM_#([/6E]&3I42:LP+NW\7 MRFPC0!24(X5-\I MYXCGN%"<.!O=\D:LTC7V",E_O6;!7R,@0:15[ _B$31Z4+@='0QN3Z/>\39L M]Z:C+?3N3V1[@QB!/Y6"L,FMSC@Q-K>(:RH4";#M>P MM)0\SCR$PBIX(+I6:/K$\+%T*"],CA"VOK"(8VV$-\"7G&/(L%Y0B&1L@9R6 M"(E@.1W0BDM)YI@$GBM>XX/!ZY)G;Z9<%9Z,*)J0)%C;R2G&P>ZHT; LV(-6 MP^WN@LTC$SLB)=I0%HYTX3X]]C[$SY?20#5O\N7M"ALMJFF_V"#, =KC@44# M/$-PB8,!UY(,0_"V04![Y++>\BT;&'L$^5%&UG%<& KR6OI[H"_5UN$3>HV( M6FR,*GXO,&^BTJ,MX001BE2T(5>:B1L8\)MYVN?[-S3!EM?!D@FWR_J 2,PC M&H1G=^]]R;QSW++?@RIW]AORU6^8D$?B]Z#V1-T_PY[(O^$3"]Q75T1#O+>. MPQ7G$)X>42AL59AH%\?ZTFECEUG9/T!E:2J= ]C)Y".-&9]:A$2;?/2#39+Z$BB_V>_O7_]SM/EH^DGG/V/;RMR"4FV<0@$U0QON"9 M"Q'BW_264*J&K"6SJ593H-25\7'YPMJ49 =IKO0^ .@(K"^,8M' MW_[EJ1&U0^)R?E]3BHP0B&!J& 3%"^U=3_!89(QC#;G MV9M*N[(!AGZ#-3T,%OH^(]K*/Y+PV=IW9H+29M!#O-=/,7QO9GGYHG-\9OUU M_0ONQCF*O1UF_G_4:#W"]^_LMC\V\C>E1\@25Q,)"7NW9(WWH>):>O^G\_L: MR=G758S=(F.F(R3-5KOJC_8\\/KIED3)DT[G?9HH_WZ2+3Q]IM.X:Z5\XPP\ MU4P^T..C6/<9:-?1JI"32%\OW^_#6>A]&GCQ/8F(S#QYO+ZVD(# MSL"K_P=>I62PDLEV.$C8/;#D;8/%29+&-'X3DXMN)SWO=I-NX,=!ZJ\Z) @Z MY+./1GJXO>;19LOIVT;&A+.A5G^O$[CG9[GIERPQFY[?:OW:J+8.!ZD4!O4I MY*\_:S%/A!GZ8!S"V5KT*I<:?\MZ2$Q[L_L?5[?KR4]HS_,>835?\Y .?/ A!.%M'T:AJ.HNE\AN=QL;P9S2*(Y@=O M^7(25C9?M-[ _ JB=Q-8CA:7H]EDZ<]Y!*56G=4J( [<&N,"K6A<9JX#?K#D T MI(PCX='R)8T+A3T)(2(B@ M%IQO,7&SG-M\>LPQ1?\HF*+V?&@;IGV0_?8).07,6O_L)#E]C/>7C'S,QEW0 M_8MV!^-ZT;>Y^C/&+SC,^#&!M2.K:PV6-T.0-<'5*A[[X!*F,+JYHMK&L6G) MA'- -K0&JQP2<@PL4BQ7R@06-KN. I/JTEL5&-Q5\#H-9$[K^J:_J0WN3]XD MCH\ZYWU=O9^ID =A9+^Z)R0TWK687H']0ME=C>'G[SX'87YC>*"XX@7T^?9W M(-:-[;!8M4; J\H]S5;8F8-V?3UX4;?\9L#+93WA]A1>9"P 3T:^/>.N/K>^ ML)"5EKPP3UG^84KN9M9J>AW\!4$L#!!0 ( &1>=U5A<@@_#P0 ,(/ M 3 831Q,C)E>&AI8FET,S(R+FAT;=57;7/:.!#^?K]B2^;29 :_8?(& ME!D"Y$J;@PXXD^NGCK!ET$267$D.X7Y]5S;0:W/-33-W+>T^^VA7 MZKP83/K1^W=#6)J,P[N;R^M1'VJ.Y]V&?<\;1 -X'?U^#4W7#R!21&AFF!2$ M>]YP7(/:TIB\Y7FKUM94T^-2:NHF)JEU.W8$WY0DW5\Z+QP' M!C(N,BH,Q(H20Q,H-!,+N$VHO@/'V&3/TP3B$LX5HE2'5OJFZ3TI;<2RY5*T#OWS:5N*D)&-\W7H9 ML8QJ&-,53&5&Q,NZ1I8XFBJ65A,U^Y,B9(A>^;O:((IV.!-TBW#0L)@.'Y9L MS@R$#;?QR->GXOC.&&/D#%7_>9!G?QMD?SB-1E>C?B\:3<:XYZ:SF]XX@FBR M]Y[/AOW2YPO_%"97$+T>PJPWO>R-AS-G\L?U\#WT^I&5-'S_^,??[?CS:/<4D7_TOAL)B*40-+;5'5;,+,$L*?2PMB9EG1Y+ M%P(PLAH6HB ^\A52J,IG#%!$;'\'^2IBRFRF)@#6W"J ..&9;B M1UXH71 $$*&;;>"UNV>C,"-J3@35SN2!TS7TXA).NWOJ6[#G5)>#V1KNA%QA M@ MZ>'!RWGY6#ABTWM)Y7ZHV"WT7[\\NTO8S\O6_R7-C/_/,!!:6K"I$6/L,0=4$1\N\;4E F$(6Y(IJ MF^^Z%1/. =70&]S_*,B1 "BQ6NFN+J#!I#PIEX4'9Q6\HHO,:57\]%^%=NVS!"8TWC:=58!=1=E:M^^&;SUZX7NON&YBU M[M.]<$^<'-AK9=DG 0\O]S2;8YMNA-59X5FM\ZNK8"ZKNW!+X='&L'OZZ'*X M59Q+8V36\C^KD+F6O#"/5?[A/KEY5[?;\I[=_0102P,$% @ 9%YW5?[! M6?! 0P *$8# ! !W8F$M,C R,C X,S$N:'1M[7UK6^)*L_;W_2OR^NS] M;.>Y#*9SCK/6[ L%7@)X/#I"D MT\>[[JJNJO[C_^XZ@7!#HM@/NW]NH8*T)?S?MS_^GRC^O7]Z+)1"I]\AW40X MB A.B"O<^DE;.'=)?"UX4=@1SL/HVK_!HLB>.0A[@\B_;">"+,GRU,5H3W%L MI&B*+2*7&**JJ(IHN:HJ8DE!AJL9FHWMGB[21-4R'=%V;564 M)&)*MF;+BB[ON'N:C1S=0Y+F&DA53-N6)86HBB%KKF1*DD1?VTZ@==#";KS7 MC\5+C'M_;K63I+>WN^OAV"Z$T>5N=F&75GDKN_G.C@)_>.OM[6V!_L)NER5) MV?6[<8*[#LGNG[CS5F'W(G58 M]MU#Q2):6[B5T '-;Y\I>+(>]+*-8S+>'>ZH/\9OUG?3BZ.*)/,+'E5B-XEP M-_;"J(,3F'6TXR51DD4T['Z73+TL)D[A,KS9A0N3XQ3[\_H'ZH5V_ZX>-YPV MZ6!Q:K3V;FT\>@H'EQ$AW=@.PR3&0>#3.PM.V&$ODDP%C35-A(I,O#"OV&.M M@TDLF6)6SEZ NY=_;I&N>-;8@@E*L/OMCPY)L$!+%7Z<2_ @[UNV"7P?O]NC]Y(HO2C[[JDRS["]1HL_',NG-RVEVG>ORC<71]95 M_>J77SVORA=7Y=O:^4^EVOQY7S_Z[E>OBO<7\+EV7T$7I:):+15OCY5:T+H/ M4>OJ\*K6:=U52[^N:_=EJ7K?]EM7E=NJ? :?G0&45BZN*E#V?KM^_E.M']7H>V_N+4A!42Q?7M:NS[)E?\"ZM>]$, M;VM7+?FB\ZM]46K=M9I5J7I^IM9+I]>UYD6[)9]>U\_/;FN=GW+MESDX;I:3 M:D.Z.VY6M-K5]6WU\K>&=<,T#"RZ2+5$U=4\$6/' $A%V),=6W(,O/4-@!#I MR+1DF!H3P_J6HYR+C4,_=G#0(C@ZA%]B/LY/C?/]G'$V=-F0D ?XJ$JNJ,J> M*=HZLD1/!FEJF#+V)%C)=!@^;(1/H/S0Y6.\T!A+<\98-A%"NN6))F"QJ'J& M*V($"]KV8)%C%]DVT;>^';;><82+,+PN&^( 7VX)J4"#8N^2/<^_(ZZ81'W" M1_NIT49S1EO'JBQA"]:Q;)I < '#;8(<4=,LHA 8'5,QMK[1_OV(\2Z1V(G\ M'B4O?'B?&EYYSO B(GD>Y;26X4BBZF@@DW73$$VD(-W0B(=->^O;^7Y1\&/! M\X$X7@I)&SX/AT!(0@'3+T(E(1T!:?0'O^L$?9? K80.?!P&OLMT,L_O F?U M<0 <#WZ@!<1"Z D^_$?Y9#* 9V](G!"R0]\1@9K1CQRR3Z)+TA4.PJ@71HRL M"MO__I<)4^-KYSB%NYB%TK8G2PB??WH MG5D5TI;"-Z;1[64+)IW6+UDP>4&$\=C\F^_2[YX/O<,J1.;J" >5'Y-\;/KA M;_E/DZ7WF'3-O\$81TD)QIF*?"1*EB@-BQI=&U;3S6^54R5D](KT2OX]?\GN M1$<]T&_$(2XRD40LU;*PK2#;4XA-5&P1S],^H-^RYI-+.OG3KRZ\[*X7^(Z? M5-.)Z_IP-;5S9#K_7B-?, U+4>V7$N15*S!)8+78S !/_:*BBY)M3 A M\0D>8#L@I3Z!)FGK.*JN9!/3,4SZ5\5$,W4L$] 0#=?5#5VUUFE456W.J.KK M.*JF)X->KWNNX2'5LQSL>*KD2;IE$VR:KO&[\HGD5&IT2^;T0'YEL1[H=_VT M^7TF]M,?.P3'_8A\RPRF>V>-4OYX?BG_3I^?*2MN8^ &,\5E@\DN/E[>[B2[ MV!VSH^VZ_DUJP])TO]L M3=Z&HTNXTPZ3).SL207)["5P1]S#P,'L:!=*3C^G+YA]S9SGO]+>%W'@7W;W M'!AA$CU2XD>7E= EGS]EAQ&,@.B$08![,=G+/WS-C9ZIE59D#WV=?(<&+[@A M4>([.,A>PMZ77AX-0$%*!R&!D4[<_,W9Y0*[M)NXL]5 M'>4W9-- 82,+ST&K:*_]N:5L334\:PKJ)0+3#H1_2>S?U^QZ$O;VY)F+/>RZ MH(+L20)BKQC589=UU&N'.G\(ZAU&>_E;/5CEHH<[?C#8^]\FP'XLU,BM[*'5'@+^WJ;=HD!Y; !S;H(R1ITXEFMTBR7A$:S MV"PWEC-;W[L)C?+!V6FE62DWA&*M))3_/OBK6#LJ"P?U:K72:%3JM<_6+GFJ M7>K<=IWCN U3+0F[.T*I<% /5)3K<_6EL7&Z+!^6A7>P<*:;@%]I!WF;FB' M:1YV:E?76DN&9YM%K0;OJ)^7[RY*+:EZ7D&U*^>V=N4&5;ERXQ[]4MV_O@<7 M#J]9Y%55+UU*K4]%:SR^%9CW MU5)9_HT.L;DL0?N\594\0JSJB1 M^:<6%@24-V)U1%S!,(V%)-QS2C7-@H24YPC.AZ1D+NCDWAT5=>/C'A!OMF_" MWM(G EH()M\!58K=;A\'IZ071LF$<9_N<._981C8. C"Q [O5A)\4B-P33Z] M@KK=U9O?V]7SVE6MY/JU^^O[ZOEW_Z)4T6KW0;O5;%^U[F>,P,K%4?6N=5_6 MJIWR74NN2C6YHM2;\%OG^W7UZEJIGQ^VZT=0YB_S]KA9G#8"6YXC2[I'X0L1 M455E SZI2-1D358\#\9%5;>^_?M?EJ%J7Q_$KVS&OWXRIVM\Z?-96F@^%VNU ML^*Q<%H^J9\VA9.ST\99L=84FG4!B$X3V(R %*%^*B!MV_TBU ^%YE]E88P# M#?E/\:!)+R/HR8DN6F&V>AA&S*+OL8U484!P)( 8(.Y[<(MTW[:<6B0F]_CH MUH+8@7>VZ6.BBP%UYXGU\^]!O?GKNM5T #2J2JVT?W5!P>/^,*B?UX+ZT=EM]:BLUCJ5 M:9ZHM3IG6NW\M%V[9W62JD>UZWK34:KG9U"',_6B6;QM-2]E *1Y/!&IIN59 MKB["("%1U14L6IZ!1(_(M@3ZKZV96L83U77GB1L:^?S2"R6'OIUKL?T^U ZB9#A&Z?;1*^N7OR(;RL MQMZUDICV8L(TJ%Y5?R-DRUCV%%'5*$G2B2I:H+***K8-I"/--F3F5HQ$13NE"VC7]ZN+9HVS->"SHO'1Z?EVG<(PYU+'$%O\N\5ITVCJ#Z7V:)VXLTMX_KC/D3 M]LT!K])U1DZ]S('J(.QWDVAP$+ID5HUC;L.]*+RAY:RHE>A= 7(P!R!U1Y=5 M67-%1#&9 M$L88*& 1,(DQE!'DV61K(='>E7,36^.\477C4@<9_\=0P40Q_>G\%V:X5J^)5W\ MW9:8*O76IHYEIG#N!YTP@:F% MW=F]P/>:+0?PL1XUPUO.R]][KES^=HFL8 E+HD$<+*JF8@"'< S1L&S+=E3- M,&R5DGH2@?H:?. L8<*['IV $N>S3"=J_U?A+"@@XN_%YJT>&+ M^]J%+G$R2\Q>OPMS MC-X%X_26_J54RD WK*QD>;G_0[U4_NUHIHT-115-B_KWZC9U$C45T2'(1K8+ MVH N;7TS56-:*'QY2[)_'-(T6W32KK!=^#4#<_9;PY+L2:HI*@K61%6R#-$T M=4TD6$?(4'7']%A'T05C7>!FP6VZP&.1[YB0\%IINS)"*N MT.M'<1^G"8D:Q&$V0R1OVU\H"Z"N:$4GV5L]EQ]44(S%O&B>4RQ2"IJV6(CW M,VMK&(OY3"]&12G'>CQ(?/;BLSE,[A#4I.E(Z6PAV&D+#LWAL0"1>M2AV2FAZO#H'YTT:XW*X-:,VC7CFKM M>JGMU^X=M7457+>8XWZM4SN?=OKO^30CX$6GK%6O*@C>([7DLEH_JB@UJ&O] MG-H ]]M5N86 N]S-\161D.9A3S%%++DV<$S#%"T96:).3%51"?RHX=3]&28U M2WBT(_PWB#LD]' DW.!@3F;(9RFI?(8_.,,S8$YQF4_O!:;W;'Y3VS)4R7%$ M59,)W6'31%.6/!$C3_8T&_0KC%D"3#Z)WQBFRYEP3/V>I_>$J.A<_>V@=YOG M,Q9DV_80,HDN(E>7156A4UP%+,>FZCF.Y"HF0<#T0$VJX=C%_Z10+E1Q=$T2 MX?CXX#5VY?69ZR])0/3R".;&M($PER/5'U=" CCF&+AD>N;7*##^2S&H6\TCK]R;G/&\=R) M/<,XB*)KR'%L459I2@]90Z(ER33-D(HTV=$,R7)3QL%GZA)0F#..)4[F&<8A M8<5 %I -)"'J 8TL$7N>)5K$4UUDJ::GOM;&L:!CD?(&^_*+3>+&<_;&+R?V MQC,OHC=U)EJD$8\Y$]7"+EG0/>+CQJ#2=6G0$A'L@>"T"4PQJ-FUX*==/19/ M[L<"%FY)$(C7W? 6ZDEP# UTX4+&(@"\?QN&FY^V@^(H$I:/FAC8PWC M5Y@]K.???)G]"H-^-\$12_@4 M??#1E>^]O)0J+"\).DYW:%9U5:;;=8HD8@N6%](<4U4\I,/JHP+BT=6UJDOB MMDU@XD;3ZV(;?1':F)W,!ZL"!\%P18PO%9MD-T"9DZMC8E6,B9.SAKPQ7@UFJVS3])-5*$YQ\]!&S[[U.[V@\V6_7 ^YF::[H>#(],M2E MSJ^N+%JV[>FF*JF.HLV5@\*$"*R%PHK+L0<6+9W-,)$[?D)/Q"0!3.@H[%(M M.!@(!#3B@5"ARC%V6+!*"2=8.$REW<2:'I4Q+O[&2>(IN>P':?1\0VS2$S.1 M;GR5%;DP9)$^RV#4HQF,WGJ!I_4=+EP2?RE,DM7WHJQCO4L[-UNYF[94[QWT MFYB&9IN.*2J2;(FJ*GFP2ATBNK;A*+8G86R8CU!680YG%9Z];M_(C_TMEBY3 MV *H/1&PX\#2C;)3;0.FK77G_@K4M2O.O1!W8,W#6Z)<:,!D[T G#*ALAM) MHM&.NA0NH_ V:>=7"R"JT[-UF7+(LJNR6+?L1-R'*I@=DYO?]N0-#U9O>",5 MT-G-#]0UOS-77Y%LBW+..,9I1N%C7/--LZ 9VDL\\[6"*K]!UDRMH"O+SSK. MBC4_*NMX'INX_-3/GQ-4WB7K;W0 *_RFE;8I7W2^MZM- MYX[9@N7*H%:BAZ67I8M.[?KBJNW7SENWU:,S>/9RVJ;<:77*=U WM77E*% W MJ=;YU6XU3SLM^;0#Y:&+J^+M1?-,KA_27*+EQ],H0,U9ZH2C[]?UHU\!E!-4 M[\L:/(\NFA?M:NF&L#:/Y_^OJ_>_K8T&=:))(E ]!01AMD0L:PKHF[( ME@J#[>CR L=H/)&6>79=39R9N[1;UV.UENL\_*4O)1]A'O$4,$S4:RX X> M-7HR4R

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end